Technical Analysis for ATH - Alterity Therapeutics Limited

Grade Last Price % Change Price Change
D 0.005 25.00% 0.001
ATH closed up 25.0 percent on Thursday, March 28, 2024, on 56 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Alterity Therapeutics Limited Description

Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Cancer Diseases Drugs Biology Cancers Disorders Geriatrics Neuroscience Psychiatric Diagnosis Alzheimer's Disease Macular Degeneration Neurological Disorders Parkinson Brain Cancer Degenerative Disease Medical Biotechnology Neurodegeneration Parkinson's Disease

Is ATH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.009
52 Week Low 0.003
Average Volume 10,748,879
200-Day Moving Average 0.006
50-Day Moving Average 0.005
20-Day Moving Average 0.004
10-Day Moving Average 0.004
Average True Range 0.001
RSI (14) 52.61
ADX 24.67
+DI 33.010
-DI 13.592
Chandelier Exit (Long, 3 ATRs) 0.003
Chandelier Exit (Short, 3 ATRs) 0.005
Upper Bollinger Bands 0.005
Lower Bollinger Band 0.004
Percent B (%b) 1.07
BandWidth 33.333
MACD Line 0.000
MACD Signal Line 0.000
MACD Histogram 0.0
Fundamentals Value
Market Cap 10.15 Million
Num Shares 2.03 Billion
EPS -0.02
Price-to-Earnings (P/E) Ratio -0.25
Price-to-Sales 735.64
Price-to-Book 9.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.007
Resistance 3 (R3) 0.006 0.006 0.006
Resistance 2 (R2) 0.006 0.005 0.006 0.006
Resistance 1 (R1) 0.005 0.005 0.006 0.006 0.006
Pivot Point 0.005 0.005 0.005 0.005 0.005
Support 1 (S1) 0.004 0.004 0.005 0.005 0.004
Support 2 (S2) 0.004 0.004 0.004 0.004
Support 3 (S3) 0.003 0.004 0.004
Support 4 (S4) 0.004